Artificial intelligence in liver cancer—new tools for research and patient management

J Calderaro, L Žigutytė, D Truhn, A Jaffe… - Nature Reviews …, 2024 - nature.com
Liver cancer has high incidence and mortality globally. Artificial intelligence (AI) has
advanced rapidly, influencing cancer care. AI systems are already approved for clinical use …

[HTML][HTML] Advances in spatial transcriptomics and its applications in cancer research

Y Jin, Y Zuo, G Li, W Liu, Y Pan, T Fan, X Fu, X Yao… - Molecular Cancer, 2024 - Springer
Malignant tumors have increasing morbidity and high mortality, and their occurrence and
development is a complicate process. The development of sequencing technologies …

Neural Network Enables High Accuracy for Hepatitis B Surface Antigen Detection with a Plasmonic Platform

W Sun, J Nan, H Xu, L Wang, J Niu, J Zhang… - Nano Letters, 2024 - ACS Publications
The detection of hepatitis B surface antigen (HBsAg) is critical in diagnosing hepatitis B virus
(HBV) infection. However, existing clinical detection technologies inevitably cause certain …

[HTML][HTML] Key requirements for advancing machine learning approaches in single entity electrochemistry

V Shkirskiy, F Kanoufi - Current Opinion in Electrochemistry, 2024 - Elsevier
Despite the noteworthy progress in Single Entity Electrochemistry (SEE) in the last decade,
the field still must undergo further advancements to attain the requisite maturity for facilitating …

Deep learning for liver cancer histopathology image analysis: A comprehensive survey

H Jiang, Y Yin, J Zhang, W Deng, C Li - Engineering Applications of …, 2024 - Elsevier
Liver cancer is the predominant cause of cancer-related fatalities globally, wherein
Hepatocellular Carcinoma (HCC) and Intrahepatic Cholangiocarcinoma (ICC) emerge as …

BiliQML: A supervised machine-learning model to quantify biliary forms from digitized whole-slide liver histopathological images

DJ Hellen, ME Fay, DH Lee… - American Journal …, 2024 - journals.physiology.org
The progress of research focused on cholangiocytes and the biliary tree during development
and following injury is hindered by limited available quantitative methodologies. Current …

[HTML][HTML] Combined hepatocellular cholangiocarcinoma: A clinicopathological update

M Vij, FH Veerankutty, A Rammohan… - World Journal of …, 2024 - ncbi.nlm.nih.gov
Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare primary liver cancer
associated with an appalling prognosis. The diagnosis and management of this entity have …

[HTML][HTML] Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies

S Gurzu, R Szodorai, I Jung, L Banias - Journal of Cancer Research and …, 2024 - Springer
Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) are the most
common primary liver cancers. Little is known about the combined hepatocellular …

Multiomics analyses decipher intricate changes in the cellular and metabolic landscape of steatotic livers upon dietary restriction and sleeve gastrectomy

S Chen, Q Zeng, X Cai, J Xue, P Song, L Tang, C Klein… - bioRxiv, 2024 - biorxiv.org
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a chronic, progressive
liver disease that encompasses a spectrum of steatosis, steatohepatitis (or MASH), and …

Intelligence artificielle en hépatologie.

C Mouliade, JF Cadranel… - Hépato-Gastro & …, 2024 - search.ebscohost.com
▼ Abstract Artificial intelligence (AI) is omnipresent in our daily lives and generates
questions about its future place in medicine, in general, and in hepatology in particular …